Evidence map›Paper›PMID 42865161›Full record

ArticleSe pu = Chinese journal of chromatography2026

[Recent advances in porous materials based silica stationary phases for liquid chromatography].

Ze-Xin Huang, Sheng Tang

Abstract readEnglish Abstract
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ze-Xin HuangSchool of Chemistry and Environmental Engineering,Wuhan Institute of Technology,Wuhan 430205,China.
Sheng TangSchool of Chemistry and Environmental Engineering,Wuhan Institute of Technology,Wuhan 430205,China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent years have seen significant progress in nanoscience and materials chemistry, driving the development of novel porous materials such as metal organic frameworks (MOFs), covalent organic frameworks (COFs), and porous organic cages (POCs). MOFs form through coordination bonds between metal ions and organic bridging ligands, COFs result from strong covalent linkages connecting predesigned organic building blocks into extended crystalline networks, and POCs are three-dimensional cage-like organic molecules with well-defined intrinsic cavities. Nowadays, the use of porous materials as stationary phases in high-performance liquid chromatography (HPLC) continues to draw sustained research interest. By precisely designing the building blocks of porous materials, researchers can flexibly modulate separation selectivity in terms of pore size, pore morphology, and interlayer stacking patterns, thus enabling the efficient separation of complex samples, particularly for positional isomers and chiral compounds. Despite their considerable promise for chromatographic applications, the direct use of porous materials as stationary phases is constrained by inherent limitations. A primary challenge lies in synthesizing pure porous materials with both regular morphology and uniform particle size. Irregular particle shapes combined with broad size distributions typically result in high column pressure and low column efficiency, which severely restricts the practical application of porous materials in HPLC. To overcome these limitations, combining porous materials with silica gel (SiO

Indexed as

covalent organic frameworks (COFs)high-performance liquid chromatography (HPLC)metal organic frameworks (MOFs)porous framework materialsporous organic cages (POCs)stationary phase

Identifiers

PMID42865161
PMCPMC13659872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.